Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery

NCT: NCT07508592 · RECRUITING

NCT IDNCT07508592
StatusRECRUITING
Start Date2026-02-17
Completion2026-09-01

Brief Summary

This is a first-in-human feasibility study designed to evaluate the safety and performance of the SEGER device in patients undergoing elective laparoscopic gastrointestinal surgery requiring intracorporeal anastomosis. The study will include patients undergoing procedures such as small bowel-small bowel and colorectal anastomoses. The SEGER device is intended to facilitate closure of enterotomies and support intracorporeal anastomosis during minimally invasive surgery. The primary objective of the study is to assess the safety of the device and its performance during surgery. Secondary objectives include evaluation of technical success, intraoperative usability, and early postoperative outcomes.

Frequently Asked Questions

What is Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery?

Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery is a clinical trial registered under NCT07508592. Current status: RECRUITING.

What is the status of NCT07508592?

The current status of NCT07508592 (Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery) is: RECRUITING.

When did Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery start?

Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery started on 2026-02-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.